These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29807532)

  • 1. LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans.
    Bagdade JD; Jilma B; Hudgins LC; Alaupovic P; McCurdy CE
    Lipids Health Dis; 2018 May; 17(1):127. PubMed ID: 29807532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.
    Alaupovic P; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Samuelsson O
    Kidney Int; 2006 May; 69(10):1865-71. PubMed ID: 16572113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
    Lee DM; Alaupovic P; Knight-Gibson C; Bagdade JD
    Eur J Clin Invest; 2008 Oct; 38(10):734-42. PubMed ID: 18761668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of interleukin-6 infusion on apo-B-containing lipoprotein subclasses in humans.
    Bagdade J; Pedersen BK; Schwenke D; Saremi A; Alaupovic P
    Scand J Clin Lab Invest; 2011 Oct; 71(6):449-55. PubMed ID: 21923231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CETP-mediated cholesteryl ester enrichment of apoB subclasses in type 1 diabetes.
    Bagdade JD; Knight-Gibson C; Simpson N; Gerkin R; Alaupovic P; Reardon C
    Eur J Clin Invest; 2012 Jul; 42(7):709-16. PubMed ID: 22288873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concept of apolipoprotein-defined lipoprotein families and its clinical significance.
    Alaupovic P
    Curr Atheroscler Rep; 2003 Nov; 5(6):459-67. PubMed ID: 14525679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease.
    Knowlton N; Wages JA; Centola MB; Alaupovic P
    Scand J Rheumatol; 2012 May; 41(3):165-9. PubMed ID: 22401593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth.
    Blackett PR; Blevins KS; Quintana E; Stoddart M; Wang W; Alaupovic P; Lee ET
    Metabolism; 2005 Feb; 54(2):180-7. PubMed ID: 15690311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins.
    Seidel D; Alaupovic P; Furman RH; McConathy WJ
    J Clin Invest; 1970 Dec; 49(12):2396-407. PubMed ID: 5480863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of decreasing renal function on lipoprotein profiles.
    Attman PO; Samuelsson O; Alaupovic P
    Nephrol Dial Transplant; 2011 Aug; 26(8):2572-5. PubMed ID: 21220758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia.
    Skulas-Ray AC; Alaupovic P; Kris-Etherton PM; West SG
    J Clin Lipidol; 2015; 9(3):360-7. PubMed ID: 26073395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-resistance and lipoprotein abnormalities.
    Fruchart JC
    Diabete Metab; 1991 May; 17(1 Pt 2):244-8. PubMed ID: 1936484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein particles LpA-I, LpA-I: A-II and LpB in coronary artery disease].
    Calvo C; Olmos A; Ulloa N; Bustos A; Toledo L; Durán D; Naveas R
    Rev Med Chil; 2000 Jan; 128(1):9-16. PubMed ID: 10883517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis.
    Marsh JB; Sparks CE
    J Clin Invest; 1979 Nov; 64(5):1229-37. PubMed ID: 227928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.
    Havel RJ; Kane JP; Kashyap ML
    J Clin Invest; 1973 Jan; 52(1):32-8. PubMed ID: 4345202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.